Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Change in Intangibles (2017 - 2025)

Historic Change in Intangibles for BeOne Medicines (BEIGF) over the last 5 years, with Q2 2025 value amounting to $20.0 million.

  • BeOne Medicines' Change in Intangibles changed N/A to $20.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year increase of 3674.28%. This contributed to the annual value of $4.7 million for FY2024, which is 7586.37% down from last year.
  • According to the latest figures from Q2 2025, BeOne Medicines' Change in Intangibles is $20.0 million.
  • Over the past 5 years, BeOne Medicines' Change in Intangibles peaked at $20.0 million during Q2 2025, and registered a low of $4.7 million during Q1 2024.
  • Over the past 3 years, BeOne Medicines' median Change in Intangibles value was $9.7 million (recorded in 2023), while the average stood at $11.0 million.